Brief: Santhera Starts Convertible Bond Exchange Offer
April 6 (Reuters) - SANTHERA PHARMACEUTICALS HOLDING AG
SANN.S :
* SANTHERA COMMENCES CONVERTIBLE BOND EXCHANGE OFFER AND
CONTINUES
TO SEEK VOTES ON THE BONDHOLDERS' RESOLUTION
* IF SANTHERA DECLARES EXCHANGE OFFER SUCCESSFUL, AN
ADDITIONAL
ACCEPTANCE PERIOD IS EXPECTED TO BEGIN ON APRIL 21, 2021, AND
END ON APRIL 27, 2021
Source text for Eikon: ID:nGNE7KcQDy
Further company coverage: SANN.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Santhera Pharmaceuticals Holding AG
See all newsSwitzerland's Santhera Pharma H1 revenue soars on AGAMREE sales, milestones
Brief: Santhera Pharmaceuticals H1 Operating Income CHF -6.562 Million
Brief: Santhera Says NXERA Plans To Submit South Korea Marketing Authorization Application 2026
Brief: Santhera Gets Positive CHMP Opinion To Expand Agamree (Vamorolone) Use
Brief: Santhera Pharmaceuticals H1 Operating Income CHF -35.444 Million